Organovo Holdings reduces at-the-market agreement to $26.56 million

Cantor Fitzgerald is selling stock through offering for 3% commission

By Devika Patel

Knoxville, Tenn., July 20 – Organovo Holdings, Inc. reduced its at-the-market program with Cantor Fitzgerald & Co. to $26.56 million from $33 million on July 20, according to an 8-K and prospectus supplement filed Wednesday with the Securities and Exchange Commission. The deal was negotiated on Dec. 30.

Cantor will be paid a 3% commission.

Based in San Diego, Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.